Targeting tough bacteria: Durham biotech startup advances synthetic antibiotic technology
It’s often said that success doesn’t happen overnight. Consider Durham-based anti-infectives startup ValanBio Therapeutics. The journey that led to the development of its new synthetic antibiotic technology – LPC-233 – began about 40 years ago. And it isn’t over yet.
Read More
